Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03699319
Title CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jeffrey Hardacre
Indications

pancreatic adenocarcinoma

Therapies

CPI-613 + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.